BE Elewski

524 total citations
9 papers, 358 citations indexed

About

BE Elewski is a scholar working on Epidemiology, Dermatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, BE Elewski has authored 9 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Dermatology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in BE Elewski's work include Nail Diseases and Treatments (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Pharmaceutical studies and practices (3 papers). BE Elewski is often cited by papers focused on Nail Diseases and Treatments (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Pharmaceutical studies and practices (3 papers). BE Elewski collaborates with scholars based in United States, Germany and France. BE Elewski's co-authors include Alison Layton, Thomas Jansen, Brigitte Dréno, Mauro Picardo, Zoé Kececioglu Draelos, Donald L. Greer, Wendy Cantrell, A.B. Gottlieb, C.F. Chiou and Bruce Strober and has published in prestigious journals such as Annals of the Rheumatic Diseases, American Journal of Transplantation and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

BE Elewski

9 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
BE Elewski United States	9	211	125	113	77	27	9	358
Maria Letizia Musumeci Italy	10	290 1.4×	52 0.4×	106 0.9×	53 0.7×	24 0.9×	23	411
Yasmeen Jabeen Bhat India	9	217 1.0×	83 0.7×	61 0.5×	16 0.2×	22 0.8×	48	307
Abbas Zamanian Iran	9	101 0.5×	184 1.5×	51 0.5×	72 0.9×	25 0.9×	34	356
Janet G. Hickman United States	10	311 1.5×	151 1.2×	77 0.7×	62 0.8×	41 1.5×	15	466
A. J. Kanwar India	12	224 1.1×	66 0.5×	219 1.9×	156 2.0×	18 0.7×	34	468
YogeshS Marfatia India	10	83 0.4×	63 0.5×	136 1.2×	93 1.2×	38 1.4×	22	328
Roger Clayton United Kingdom	11	159 0.8×	113 0.9×	63 0.6×	48 0.6×	24 0.9×	23	339
VikramK Mahajan India	10	92 0.4×	129 1.0×	104 0.9×	42 0.5×	16 0.6×	20	294
P. Gamborg Nielsen Sweden	10	185 0.9×	157 1.3×	120 1.1×	12 0.2×	17 0.6×	32	348
Bridget Kaufman United States	6	373 1.8×	25 0.2×	62 0.5×	86 1.1×	21 0.8×	15	445

Countries citing papers authored by BE Elewski

Since Specialization

Citations

This map shows the geographic impact of BE Elewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by BE Elewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BE Elewski more than expected).

Fields of papers citing papers by BE Elewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by BE Elewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by BE Elewski. The network helps show where BE Elewski may publish in the future.

Co-authorship network of co-authors of BE Elewski

This figure shows the co-authorship network connecting the top 25 collaborators of BE Elewski. A scholar is included among the top collaborators of BE Elewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with BE Elewski. BE Elewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Yosipovitch, Gil, Jennifer Soung, Jerrold Weiss, et al.. (2019). Secukinumab Provides Rapid Relief From Itching and Pain in Patients with Moderate-to-Severe Psoriasis: Patient Symptom Diary Data from Two Phase 3, Randomized, Placebo-controlled Clinical Trials. Acta Dermato Venereologica. 99(9). 820–821. 14 indexed citations

Canavan, Theresa N., John W. Baddley, Peter Pavlidakey, José Tallaj, & BE Elewski. (2017). Human polyomavirus-7–associated eruption successfully treated with acitretin. American Journal of Transplantation. 18(5). 1278–1284. 18 indexed citations

Elewski, BE, et al.. (2017). AB0756 Primary efficacy and safety of adalimumab in nail psoriasis from the first 26 weeks of a phase-3, randomized, placebo-controlled trial with subanalysis in patients with and without psoriatic arthritis. Annals of the Rheumatic Diseases. 76. 1319–1320. 8 indexed citations

Leonardi, C., Bruce Strober, A.B. Gottlieb, et al.. (2010). Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study.. PubMed. 9(8). 928–37. 66 indexed citations

Elewski, BE, Zoé Kececioglu Draelos, Brigitte Dréno, et al.. (2010). Rosacea – global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. Journal of the European Academy of Dermatology and Venereology. 25(2). 188–200. 141 indexed citations

Cantrell, Wendy, et al.. (2009). Onychomycosis and diabetes. Journal of the European Academy of Dermatology and Venereology. 23(10). 1119–1122. 36 indexed citations

Cantrell, Wendy, et al.. (2008). Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis. Journal of the European Academy of Dermatology and Venereology. 23(1). 42–45. 21 indexed citations

Elewski, BE, et al.. (1998). Tinea capitis: fluconazole in Trichophyton tonsurans infection.. Pediatric Dermatology. 15(3). 229–232. 12 indexed citations

Elewski, BE & Donald L. Greer. (1991). Hendersonula toruloidea and Scytalidium hyalinum. Review and update.. PubMed. 127(7). 1041–4. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact